drugset / Trial / NCT04060316
GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
This clinical trial will evaluate the safety, tolerability and effectiveness of GLS-1200 nasal spray in addition to the standard of care after endoscopic sinus surgery in people with chronic sinusitis.
Timeline
- Start
- 2023-12
- Primary completion
- 2023-12
- Completion
- 2024-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quinine | Small molecule | 1 mg/ml | Intranasal |